Announcement – NMA and Gilead Partner to Address HIV/AIDS Health Disparities
Friday, February 7, 2020
The National Medical Association, the collective voice of African American physicians and leading voice for parity and justice in medicine, is pleased to announce a national health partnership with Gilead Sciences, Inc. The goal of the partnership is to support the NMA's efforts to reduce the number and prevalence of new HIV cases by developing and delivering customized clinical education sessions, policy development programs and HIV/AIDS prevention and education activities throughout the United States.
For more than 30 years, Gilead has built a culture of excellence. They are committed, hardworking and passionate about improving the lives of the patients who use their products. Their values – integrity, inclusion, teamwork, accountability and excellence – are evident in their activities, and are complementary to the values and mission of the NMA.
“Although African Americans represent 13% of the U.S. population, they account for 44% of HIV infection cases in 2016; thus, with the support of Gilead, the NMA will be able to make significant strides in 2020 to address and eliminate health disparities in the area of HIV/AIDS educational awareness”, commented NMA President Dr. Oliver T. Brooks.
“Gilead is pleased to support the National Medical Association's work to address and eliminate health disparities, especially in the area of HIV educational awareness. We believe this is the time to bring all providers together, regardless of specialty, to align with the Administration’s End the Epidemic Plan in order to prevent new HIV infections in those at risk and improve the health and wellness of those living with HIV.” said Dr. David Piontkowsky, Vice President of Medical Affairs for Gilead Sciences.